About Lehe
乐于心,和与众,与己乐,与人和; 心宽念纯,百病无生。
Standing at the crossroads of critical illness treatment, Professor Zhang Minghui entered the field as an immunology researcher, constructing Lehe MedNeo’s “Trinity” shared decision-making system among doctors, researchers, and patients. With a broad international perspective, Lehe MedNeo’s Second Medical Opinion always stands at the forefront of critical illness treatment.
Doctor · Researcher · Patient
Professor Zhang Minghui, with the identity of an immunology researcher, constructed Lehe MedNeo’s innovative “Trinity” shared decision-making system. This system breaks the traditional single-doctor decision model, bringing together clinical physicians, research scientists, and patients to jointly formulate the optimal treatment strategy for critical illnesses.